Nirmatrelvir for Adult Outpatients with Covid-19

N Engl J Med. 2024 Aug 1;391(5):477. doi: 10.1056/NEJMc2407058.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Ambulatory Care / methods
  • Ambulatory Care / statistics & numerical data
  • COVID-19 / diagnosis
  • COVID-19 / mortality
  • COVID-19 Drug Treatment* / adverse effects
  • COVID-19 Drug Treatment* / methods
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Drug Combinations
  • Hospitalization / statistics & numerical data
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Viral Protease Inhibitors*

Substances

  • Drug Combinations
  • nirmatrelvir and ritonavir drug combination
  • Viral Protease Inhibitors